Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: anastrozole|DRUG: gefitinib
Sponsor: The University of Texas Health Science Center at San Antonio